FDA Inspection 1195865 — Synapse Biomedical Inc
The FDA completed an inspection of Synapse Biomedical Inc on Jan 18, 2023 in Oberlin, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 18, 2023
- Fiscal Year
- 2023
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Oberlin, OH (United States)